抗ピリン市場：製品タイプ、用途、エンドユーザー、流通チャネル、年齢層、治療クラス別-2025-2030年世界予測

抗ピリン市場は、2023年に3億6,322万米ドルと評価され、2024年には3億8,299万米ドルに達すると予測され、CAGR 4.34%で成長し、2030年には4億8,929万米ドルに達すると予測されています。

抗ピリンは、主に鎮痛解熱剤として使用される医薬化合物で、医療分野でさまざまな用途が見出されています。抗ピリンの必要性は、痛みを和らげ、熱を下げるその効能から生じ、いくつかの市販薬や処方薬の製剤に不可欠な成分となっています。最終用途の範囲には、耳の痛みや炎症を和らげるための点耳液への配合や、薬物動態学的特性による診断用途への潜在的な使用が主に含まれます。市場の洞察によると、抗ピリンの成長は、耳の感染症の有病率の増加、効果的な疼痛管理ソリューションに対する需要の高まり、ドラッグデリバリーシステムの進歩などの要因によって影響を受けています。抗ピリンの潜在的な可能性は、より包括的な疼痛緩和の選択肢を求める消費者層の拡大に対応した、新しい薬剤の組み合わせや製剤における抗ピリンの役割の探求にあります。これには、特に標的治療薬として、抗ピリンをベースとした薬剤のバイオアベイラビリティと有効性を高めるためのナノテクノロジーにおける新たな研究の活用が含まれます。しかし、市場は厳しい規制の枠組み、長期使用に伴う副作用の可能性、代替療法との競合といった課題に直面しており、これが成長を阻害する要因となっています。新たな機会を捉えるため、企業はドラッグデリバリーや個別化医療のイノベーションに注力し、特定の人口動態のニーズに応える必要があります。研究機関と連携してそのメカニズムを詳細に調査し、新たな治療適応症を発見することがブレークスルーをもたらし、市場での存在感を高める。さらに、十分なサービスを受けていない市場で戦略的パートナーシップを結び、地理的な範囲を拡大することが成長を後押しする可能性があります。市場の競争は激しいが将来性はあり、業界のプレーヤーは適応力と先見性を維持し、コンプライアンスを確保し、安全性の懸念に対処する一方で、革新的なアプリケーションを模索し、市場の関連性とリーダーシップを維持することが求められます。

市場力学：急速に進化する抗ピリン市場の主要市場インサイトを公開

抗ピリン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 抗炎症作用に注目した調査活動の拡大。
  • 市場力学に影響を及ぼす抗ピリンの市販薬に対する需要の高まり
  • より良い臨床結果を得るための抗ピリンを用いた併用療法の開発への注目の高まり
  • ジェネリック抗ピリンの開発に対する政府の取り組みと資金援助が市場の成長を後押し
• 市場抑制要因
  • 抗ピリンに関連する潜在的な副作用や安全性の懸念に対する監視や社会的認知の高まりが、消費者の信頼や売上に影響を与えていること。
  • 抗ピリンの製造に必要な高品質の原材料の調達と安定供給における課題。
• 市場機会
  • ヘルスケア投資の増加による抗ピリンの医薬品製剤への需要の増加
  • ペットの飼育率上昇による動物用医薬品への抗ピリン用途の拡大
  • 高齢化傾向による疼痛管理ソリューションにおける抗ピリンのニーズの高まり
• 市場の課題
  • 抗ピリン業界におけるサプライチェーンの混乱と原材料価格の変動への対応
  • 抗ピリン生産プロセスにおける最先端技術の進歩とイノベーションの導入

ポーターの5つの力：抗ピリン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、抗ピリン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：抗ピリン市場における外部からの影響の把握

外部マクロ環境要因は、抗ピリン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析抗ピリン市場における競合情勢の把握

抗ピリン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス抗ピリン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、抗ピリン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨抗ピリン市場における成功への道筋を描く

抗ピリン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 抗ピリンの抗炎症特性に焦点を当てた調査活動の拡大
    • 市販薬の需要の高まりが市場力学に影響を与える
    • より良い臨床結果を得るために、抗ピリンを特徴とする併用療法の開発に重点を置く
    • ジェネリック医薬品の開発に対する政府の取り組みと資金提供が市場の成長を後押し
  • 抑制要因
    • アンチピリンに関連する潜在的な副作用と安全性の懸念に対する監視と一般の認識が高まり、消費者の信頼と売上に影響を与えています。
    • アンチピリンの製造に必要な高品質の原材料の調達と安定供給の確保が課題であり、生産効率に影響を与える可能性があります。
  • 機会
    • ヘルスケア投資の増加により、医薬品処方における抗ピリンの需要が増加
    • ペットの飼育率の上昇により獣医薬における抗ピリンの応用が拡大
    • 人口の高齢化の動向により、疼痛管理ソリューションにおける抗ピリンの需要が高まっています
  • 課題
    • 抗ピリン業界におけるサプライチェーンの混乱と原材料価格の変動の管理
    • 抗ピリンの生産プロセスに最先端の技術進歩と革新を導入
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 抗ピリン市場：製品タイプ別

• カプセル
• 注射可能
• 液体
• 粉
• タブレット

第7章 抗ピリン市場：用途別

• 抗炎症
• 関節炎
• 風邪とインフルエンザ
• 解熱
• 痛みの緩和

第8章 抗ピリン市場：エンドユーザー別

• クリニック
• ホームケア
• 病院
• 調査機関

第9章 抗ピリン市場：流通チャネル別

• ドラッグストア
• 病院薬局
• オンライン薬局
• 小売薬局

第10章 抗ピリン市場：年齢層別

• 大人
• 老年医学
• 小児科

第11章 抗ピリン市場治療クラス別

• 鎮痛剤
• 解熱剤
• NSAIDs

第12章 南北アメリカの抗ピリン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の抗ピリン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの抗ピリン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. AbbVie
• 2. Amgen
• 3. AstraZeneca
• 4. Bayer
• 5. Bristol-Myers Squibb
• 6. Eli Lilly and Company
• 7. Gilead Sciences
• 8. GlaxoSmithKline
• 9. Hoffmann-La Roche
• 10. Johnson & Johnson
• 11. Merck & Co.
• 12. Novartis
• 13. Novo Nordisk
• 14. Pfizer
• 15. Roche
• 16. Sanofi
• 17. Shionogi
• 18. Sun Pharmaceutical
• 19. Takeda Pharmaceutical Company
• 20. Teva Pharmaceutical Industries

LIST OF FIGURES

• FIGURE 1. ANTIPYRINE MARKET RESEARCH PROCESS
• FIGURE 2. ANTIPYRINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTIPYRINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANTIPYRINE MARKET DYNAMICS
• TABLE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY COLD AND FLU, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY FEVER REDUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANTIPYRINE MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANTIPYRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANTIPYRINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANTIPYRINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANTIPYRINE MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANTIPYRINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANTIPYRINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ANTIPYRINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ANTIPYRINE MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ANTIPYRINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ANTIPYRINE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTIPYRETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL ANTIPYRINE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. CANADA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. CANADA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 61. CANADA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 88. CHINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. CHINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. CHINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. CHINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. CHINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 93. CHINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 94. INDIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. INDIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. INDIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. INDIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 99. INDIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 197. ITALY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. ITALY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ITALY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 200. ITALY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. ITALY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 202. ITALY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 221. POLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. POLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. POLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. POLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 225. POLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 226. POLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 227. QATAR ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. QATAR ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. QATAR ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. QATAR ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. QATAR ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 232. QATAR ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 262. SWEDEN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 268. SWITZERLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 274. TURKEY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
• TABLE 286. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
• TABLE 287. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 288. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023

The Antipyrine Market was valued at USD 363.22 million in 2023, expected to reach USD 382.99 million in 2024, and is projected to grow at a CAGR of 4.34%, to USD 489.29 million by 2030.

Antipyrine, a pharmaceutical compound primarily used as an analgesic and antipyretic, has found various applications in the medical field. The necessity for antipyrine arises from its efficacy in alleviating pain and reducing fever, making it an essential component in the formulation of several over-the-counter and prescription medications. The end-use scope primarily includes its incorporation in ear drop solutions to relieve ear pain and inflammation and its potential use in diagnostic applications due to its pharmacokinetic properties. Market insights indicate that the growth of antipyrine is influenced by factors such as increased prevalence of ear infections, rising demand for effective pain management solutions, and advancements in drug delivery systems. A potential opportunity lies in the exploration of antipyrine's role in novel drug combinations and formulations, catering to an expanding consumer base seeking more comprehensive pain relief options. This includes leveraging emerging research in nanotechnology to enhance the bioavailability and efficacy of antipyrine-based medications, particularly for targeted therapies. However, the market faces challenges such as stringent regulatory frameworks, potential side effects associated with prolonged use, and competition from alternative therapies, which can impede growth. To capture emerging opportunities, businesses should focus on innovations in drug delivery and personalized medicine, catering to specific demographic needs. Collaborating with research institutions for in-depth studies on antipyrine's mechanism and discovering new therapeutic indications can lead to breakthroughs, fortifying market presence. Additionally, expanding geographic reach through strategic partnerships in underserved markets could bolster growth. The market is competitive yet promising, urging industry players to remain adaptive and forward-thinking, ensuring compliance and addressing safety concerns while exploring innovative applications to sustain market relevance and leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antipyrine Market

The Antipyrine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
  • Escalating demand for over-the-counter antipyrine medications influencing market dynamics
  • Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
  • Government initiatives and funding for the development of generic antipyrine medications boosting market growth
• Market Restraints
  • The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
  • The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
• Market Opportunities
  • Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
  • Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
  • Growing need for antipyrine in pain management solutions spurred by aging population trends
• Market Challenges
  • Managing supply chain disruptions and raw material price volatility in the antipyrine industry
  • Implementing cutting-edge technological advancements and innovation in the antipyrine production process

Porter's Five Forces: A Strategic Tool for Navigating the Antipyrine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antipyrine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antipyrine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antipyrine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antipyrine Market

A detailed market share analysis in the Antipyrine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antipyrine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antipyrine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antipyrine Market

A strategic analysis of the Antipyrine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antipyrine Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shionogi, Sun Pharmaceutical, Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries.

Market Segmentation & Coverage

This research report categorizes the Antipyrine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Capsules, Injectable, Liquid, Powder, and Tablets.
• Based on Application, market is studied across Anti-Inflammatory, Arthritis, Cold and Flu, Fever Reduction, and Pain Relief.
• Based on End User, market is studied across Clinics, Homecare, Hospitals, and Research Institutes.
• Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
• Based on Therapeutic Class, market is studied across Analgesics, Antipyretics, and NSAIDs.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
    • 5.1.1.2. Escalating demand for over-the-counter antipyrine medications influencing market dynamics
    • 5.1.1.3. Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
    • 5.1.1.4. Government initiatives and funding for the development of generic antipyrine medications boosting market growth
  • 5.1.2. Restraints
    • 5.1.2.1. The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
    • 5.1.2.2. The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
  • 5.1.3. Opportunities
    • 5.1.3.1. Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
    • 5.1.3.2. Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
    • 5.1.3.3. Growing need for antipyrine in pain management solutions spurred by aging population trends
  • 5.1.4. Challenges
    • 5.1.4.1. Managing supply chain disruptions and raw material price volatility in the antipyrine industry
    • 5.1.4.2. Implementing cutting-edge technological advancements and innovation in the antipyrine production process
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Antipyrine Market, by Product Type

• 6.1. Introduction
• 6.2. Capsules
• 6.3. Injectable
• 6.4. Liquid
• 6.5. Powder
• 6.6. Tablets

7. Antipyrine Market, by Application

• 7.1. Introduction
• 7.2. Anti-Inflammatory
• 7.3. Arthritis
• 7.4. Cold and Flu
• 7.5. Fever Reduction
• 7.6. Pain Relief

8. Antipyrine Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Homecare
• 8.4. Hospitals
• 8.5. Research Institutes

9. Antipyrine Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Drug Stores
• 9.3. Hospital Pharmacies
• 9.4. Online Pharmacies
• 9.5. Retail Pharmacies

10. Antipyrine Market, by Age Group

• 10.1. Introduction
• 10.2. Adults
• 10.3. Geriatrics
• 10.4. Pediatrics

11. Antipyrine Market, by Therapeutic Class

• 11.1. Introduction
• 11.2. Analgesics
• 11.3. Antipyretics
• 11.4. NSAIDs

12. Americas Antipyrine Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Antipyrine Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Antipyrine Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie
• 2. Amgen
• 3. AstraZeneca
• 4. Bayer
• 5. Bristol-Myers Squibb
• 6. Eli Lilly and Company
• 7. Gilead Sciences
• 8. GlaxoSmithKline
• 9. Hoffmann-La Roche
• 10. Johnson & Johnson
• 11. Merck & Co.
• 12. Novartis
• 13. Novo Nordisk
• 14. Pfizer
• 15. Roche
• 16. Sanofi
• 17. Shionogi
• 18. Sun Pharmaceutical
• 19. Takeda Pharmaceutical Company
• 20. Teva Pharmaceutical Industries